Stocks · Healthcare · Biotechnology
Nutriband Inc. NTRB
$7.28 -1.09% Close, Oct 2, 2026 · NASDAQ · Market cap $88.5M
Next earnings report: Dec 7, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -435.6% from -264.1% a year earlier.
- Revenue over the last four quarters was $1.6M, down 37.3% from a year earlier, slowing from -24.8% a quarter earlier.
- The stock is in an uptrend: above its 200-day average for 30 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 12%
- Revenue growth, 3-year CAGRBottom 22%
- Revenue growth accelerationBottom 16%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 7%
- Gross marginBottom 22%
- Operating marginBottom 17%
- Accruals (lower is better)Top 3%
- Interest coverBottom 9%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 50%
- Free-cash-flow yieldTop 49%
- EBITDA / enterprise valueBottom 43%
- Sales / enterprise valueBottom 12%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 13%
- 6-month returnTop 8%
- 1-year return vs S&P 500Bottom 43%
- Distance from 52-week highTop 33%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsTop 25%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 8%
- Maximum drawdown, 3 yearsBottom 44%
- Beta vs S&P 500 (lower is better)Bottom 45%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -24.8% | -37.3% | ↓ |
| Gross margin | 33.5% | 33.1% | ↓ |
| Operating margin | -264.1% | -435.6% | ↓ |
| FCF margin | -191.7% | -224.5% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -37.3% | -24.8% | ↓ | Bottom 12% |
| Gross margin | 33.1% | 33.5% | ↓ | Bottom 22% |
| Operating margin | -435.6% | -264.1% | ↓ | Bottom 17% |
| Net margin | -430.4% | -398.3% | ↓ | — |
| Free-cash-flow margin | -224.5% | -191.7% | ↓ | — |
| Return on invested capital | -127.0% | — | Bottom 7% | |
| Revenue growth, 3-year CAGR | -0.7% | — | Bottom 22% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -52.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 210.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -48.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -339.3×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.08%
- Shareholder yield
- -0.08%
- Share count change, 1 year
- +8.4%
- Share count change, 3-year CAGR
- +15.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 31, 2026 (filed Sep 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- +0.2%
- Positive 20 days after report
- 5 of 8
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Sep 4, 2026 | — | +6.0% | +23.6% | +29.3% | — |
| Jun 11, 2026 | +94.7% | +3.2% | -10.3% | -13.2% | +75.1% |
| Apr 29, 2026 | +97.9% | +0.8% | +8.5% | -9.3% | -20.7% |
| Dec 16, 2025 | +94.4% | -7.2% | -9.5% | -12.2% | -22.9% |
| Sep 9, 2025 | -1147.1% | -2.9% | +7.7% | +25.2% | -26.2% |
| May 30, 2025 | +7.7% | +0.6% | +12.4% | +23.5% | -0.8% |
| Apr 28, 2025 | -316.7% | +9.8% | +19.7% | +3.0% | +62.4% |
| Dec 3, 2024 | +0.0% | -9.0% | -9.5% | +3.5% | +51.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Sep 4, 2026 | -$0.07 | — | — | $437,514 |
| Jun 11, 2026 | -$0.10 | -$1.89 | +94.7% | $433,399 |
| Apr 29, 2026 | -$0.04 | -$1.89 | +97.9% | $400,709 |
| Dec 16, 2025 | -$0.12 | -$2.13 | +94.4% | $346,058 |
| Sep 9, 2025 | -$2.12 | -$0.17 | -1147.1% | $622,000 |
| May 30, 2025 | -$0.12 | -$0.13 | +7.7% | $667,000 |
| Apr 28, 2025 | -$0.50 | -$0.12 | -316.7% | $642,000 |
| Dec 3, 2024 | -$0.12 | -$0.12 | +0.0% | $646,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 4.6× | — | — | — |
| EV / Sales | 52.71× | — | — | Bottom 12% |
| Free-cash-flow yield | -4.10% | — | — | Top 49% |
| Earnings yield | -7.86% | — | — | Top 50% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 36
- Days above the 200-day average
- 30
- 50-day average slope (20 days)
- +49.1%
- 200-day average slope (20 days)
- +5.9%
- Distance from 50-day average
- +43.1%
- Distance from 200-day average
- +73.7%
- RSI (14)
- 55.6
- Relative volume
- 0.31×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 101.9%
- Volatility vs own 5-year history
- 61th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.20
- Correlation with S&P 500
- 0.16
- Current drawdown from 1-year high
- -19.0%
- Maximum drawdown, 3 years
- -73.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 31, 2021 | Oct 26, 2023 | -77.7% | 457 days | 184 days (Jul 24, 2024) |
| Jul 2, 2025 | Aug 3, 2026 | -73.8% | 272 days | Not yet recovered |
| Oct 12, 2021 | Dec 20, 2021 | -67.7% | 48 days | 8 days (Dec 31, 2021) |
| Jul 24, 2024 | Sep 11, 2024 | -58.5% | 34 days | 91 days (Jan 23, 2025) |
| Jan 23, 2025 | Apr 10, 2025 | -52.3% | 54 days | 56 days (Jul 2, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $88.5M
- EPS, diluted (TTM)
- -$0.57
- Revenue (TTM)
- $1.6M
- 52-week range
- $2.80 – $9.19
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.4M | $2.1M | $2.1M | $2.1M | $2.0M |
| Gross profit | $504,310 | $750,409 | $862,105 | $699,302 | $566,308 |
| Operating income | -$3.9M | -$4.1M | -$4.9M | -$6.7M | -$8.3M |
| Net income | -$8.4M | -$4.8M | -$5.5M | -$10.5M | -$8.2M |
| EPS (diluted) | -$1.06 | -$0.57 | -$0.69 | -$0.99 | -$2.58 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $645,796 | $642,379 | $667,432 | $622,452 | $346,058 | $400,709 | $433,399 | $437,514 |
| Net income | -$1.4M | -$5.5M | -$1.4M | -$2.0M | -$3.9M | -$968,059 | -$1.2M | -$880,561 |
| EPS (diluted) | -$0.12 | -$0.51 | -$0.12 | -$2.12 | -$0.32 | -$0.08 | -$0.10 | -$0.07 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$2.8M | -$3.0M | -$3.5M | -$4.6M | -$5.1M |
| Capital expenditure | -$81,595 | -$79,304 | -$51,761 | -$92,043 | -$5,320 |
| Free cash flow | -$2.9M | -$3.1M | -$3.6M | -$4.7M | -$5.1M |
| Dividends paid | -$196,589 | $0 | $0 | $0 | $0 |
| Net share buybacks | $6.3M | -$119,006 | $2.6M | $8.3M | $5.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $3.4M
- Total assets
- $6.3M
- Total liabilities
- $964,358
- Total debt
- $194,620
- Net debt
- -$3.2M
- Shareholders’ equity
- $5.3M
As of Jul 31, 2026 (filed Sep 4, 2026).
Short interest
- Shares sold short
- 177,805
- Days to cover
- 2.18
- Change vs previous report
- +3.1%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Aug 12, 2022
- 583-for-500
- Jul 24, 2019
- 1-for-4